Dry eye research reveals impact of disease, potential new treatments
10 March 2022
Low-dose naltrexone decreased ocular pain and improved quality of life in patients with neuropathic corneal pain, which is caused by damage or disease of the somatosensory nervous system that innervates the cornea. The study showed a 50% reduction on the ocular pain score. It also showed increased quality of life score .